nifedipine has been researched along with Arterial Obstructive Diseases in 35 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effectiveness of verapamil in the management of patients with unstable angina pectoris associated with obstructive coronary artery disease was evaluated in 2 double-blind placebo-controlled randomized clinical trials." | 9.05 | Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials. ( Conti, CR; Mehta, J, 1982) |
| "The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 7.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
| "The effectiveness of verapamil in the management of patients with unstable angina pectoris associated with obstructive coronary artery disease was evaluated in 2 double-blind placebo-controlled randomized clinical trials." | 5.05 | Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials. ( Conti, CR; Mehta, J, 1982) |
| "We investigated the effects of nilvadipine, a calcium antagonist, on cerebral ischemia in rats." | 3.68 | Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats. ( Fukasawa, H; Kawamura, S; Shirasawa, M; Yasui, N, 1991) |
| "The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 3.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
| "Vasospasm may be one of the causes of amaurosis fugax." | 1.28 | Recurrent attacks of amaurosis fugax treated with calcium channel blocker. ( Teman, AJ; Winterkorn, JM, 1991) |
| "Ergotism is an uncommon drug reaction that may lead to severe ischemic vasoconstriction, which is usually unilateral and more commonly involves the lower extremities." | 1.27 | Brachial artery stenosis secondary to ergotism and responsive to nifedipine. ( Borges, AA; Jabaji, GJ; Lin, CC; Thomas, WL, 1986) |
| "Nifedipine was given bucally in a dose (10 or 20 mg) that decreased aortic pressure 5 mm Hg or more." | 1.27 | Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion. ( Conti, CR; Feldman, RL; Hill, JA; Pepine, CJ, 1985) |
| "Diltiazem was not significantly different from placebo." | 1.27 | Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure. ( Epstein, SE; Patterson, RE; Urquhart, J, 1985) |
| "In the absence of coronary stenosis, intracoronary infusion of ergonovine (0." | 1.27 | Myocardial ischaemia produced by ergonovine-induced vasoconstriction during preexisting coronary stenosis: experimental conditions for the geometric theory. ( Fukuzaki, H; Kawashima, S; Okada, T; Sakamoto, S; Yokoyama, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (74.29) | 18.7374 |
| 1990's | 6 (17.14) | 18.2507 |
| 2000's | 3 (8.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, N | 1 |
| Dalmia, S | 1 |
| Deka, D | 1 |
| Mittal, S | 1 |
| Beinart, C | 1 |
| Sos, TA | 1 |
| Saddekni, S | 1 |
| Weiner, MA | 1 |
| Sniderman, KW | 1 |
| Hollman, J | 1 |
| Gruentzig, AR | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| Ischinger, T | 1 |
| Meier, B | 1 |
| Olson, LA | 1 |
| Faber, DB | 1 |
| LeMar, JV | 1 |
| Routman, BN | 1 |
| Hoff, GL | 1 |
| Bergey, JL | 1 |
| Wendt, RL | 1 |
| Nocella, K | 1 |
| McCallum, JD | 1 |
| Fisher, MM | 1 |
| Snart, AG | 1 |
| Mehta, J | 1 |
| Conti, CR | 2 |
| Lorentsen, E | 1 |
| Landmark, K | 1 |
| Hashimoto, H | 1 |
| Suzuki, K | 1 |
| Miyake, S | 1 |
| Nakashima, M | 1 |
| Weintraub, WS | 1 |
| Hattori, S | 1 |
| Agarwal, J | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Helfant, RH | 1 |
| Hodara, M | 1 |
| Doering, G | 1 |
| Doering, F | 1 |
| Podhaisky, H | 1 |
| Hänsgen, K | 1 |
| Preuss, EG | 1 |
| Kröger, K | 2 |
| Massalha, K | 2 |
| Rudofsky, G | 2 |
| Forbes, CD | 1 |
| Lowe, GD | 1 |
| MacLaren, M | 1 |
| Shaw, BG | 1 |
| Dickinson, JP | 1 |
| Kieffer, G | 1 |
| Buss, C | 1 |
| Harrell, FE | 1 |
| Shih, YC | 1 |
| Henry, PD | 1 |
| Shuchleib, R | 1 |
| Clark, RE | 1 |
| Perez, JE | 1 |
| Pola, P | 1 |
| Savi, L | 1 |
| Dal Lago, A | 1 |
| Zucchiatti, V | 1 |
| Pettenazzo, A | 1 |
| Gamba, P | 1 |
| Salmistraro, G | 1 |
| Feltrin, GP | 1 |
| Saia, SO | 1 |
| Winterkorn, JM | 1 |
| Teman, AJ | 1 |
| Kawamura, S | 1 |
| Shirasawa, M | 1 |
| Fukasawa, H | 1 |
| Yasui, N | 1 |
| Barillà, F | 1 |
| Pelliccia, F | 1 |
| Valente, A | 1 |
| Cianfrocca, C | 1 |
| Romeo, F | 1 |
| Reale, A | 1 |
| Mayerhofer, S | 1 |
| Stio, F | 1 |
| Battisti, G | 1 |
| Marigliani, M | 1 |
| Maceroni, M | 1 |
| Maglietta, AM | 1 |
| Muratori, L | 1 |
| Messinetti, S | 1 |
| Bache, RJ | 1 |
| Quanbeck, D | 1 |
| Homans, DC | 1 |
| Dai, XZ | 1 |
| Griffin, B | 1 |
| Timmis, AD | 1 |
| Sowton, E | 1 |
| Borges, AA | 1 |
| Lin, CC | 1 |
| Jabaji, GJ | 1 |
| Thomas, WL | 1 |
| Burgos, RR | 1 |
| Novoa, D | 1 |
| Schulz, W | 1 |
| Jost, S | 1 |
| Kober, G | 1 |
| Kaltenbach, M | 1 |
| Brown, BG | 1 |
| Feldman, RL | 1 |
| Hill, JA | 1 |
| Pepine, CJ | 1 |
| Urquhart, J | 1 |
| Epstein, SE | 1 |
| Patterson, RE | 1 |
| Yokoyama, M | 1 |
| Sakamoto, S | 1 |
| Kawashima, S | 1 |
| Okada, T | 1 |
| Fukuzaki, H | 1 |
| Bolognini, G | 1 |
| Iezzi, GB | 1 |
| Crottogini, AJ | 1 |
| Depaoli, JR | 1 |
| Barra, JG | 1 |
| Fischer, EC | 1 |
| Rodríguez Chatruc, M | 1 |
| Pichel, RH | 1 |
| de la Fuente, L | 1 |
2 reviews available for nifedipine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Peripheral arterial occlusion in infants--a report of two cases treated conservatively.
Topics: Arterial Occlusive Diseases; Catheterization, Peripheral; Drug Therapy, Combination; Echocardiograph | 1991 |
Response of normal and diseased epicardial coronary arteries to vasoactive drugs: quantitative arteriographic studies.
Topics: Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Coron | 1985 |
4 trials available for nifedipine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Verapamil therapy for unstable angina pectoris: review of double-blind placebo-controlled randomized clinical trials.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Diseas | 1982 |
Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Arterial Occlusive Diseases; Atenolol; Calcium Channel Blockers; | 1999 |
Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals.
Topics: Angina Pectoris; Angiography; Arterial Occlusive Diseases; Collateral Circulation; Coronary Disease; | 1990 |
Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Clinical Trials as Topic; Collateral Circ | 1985 |
29 other studies available for nifedipine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Fe | 2008 |
Arterial spasm during renal angioplasty.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Arteriosclerosis; Child; | 1983 |
Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach.
Topics: Acute Disease; Angioplasty, Balloon; Arterial Occlusive Diseases; Coronary Artery Bypass; Coronary V | 1983 |
Fibromuscular hyperplasia of the brachial artery--failure of calcium antagonist therapy.
Topics: Adult; Arterial Occlusive Diseases; Brachial Artery; Female; Fibromuscular Dysplasia; Humans; Nifedi | 1984 |
Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Calcium Channel Blockers | 1984 |
Nifedipine in ulnar artery occlusion.
Topics: Adult; Arterial Occlusive Diseases; Brachial Artery; Fingers; Forearm; Hand; Humans; Male; Nifedipin | 1984 |
The acute effects of nifedipine on calf and forefoot blood flow in patients with peripheral arterial insufficiency.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Blood Pressure; Foot; Humans; Leg; Nifedipine; Pyridi | 1983 |
Effects of calcium antagonists on the electrical alternans of the ST segment and on associated mechanical alternans during acute coronary occlusion in dogs.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Disease; Dil | 1983 |
Variable effect of nifedipine on myocardial blood flow at three grades of coronary occlusion in the dog.
Topics: Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs | 1981 |
[Treatment of stage II arteriopathy of the lower limbs with coronary involvement (author's transl)].
Topics: Arterial Occlusive Diseases; Arteries; Coronary Disease; Diltiazem; Humans; Leg; Nifedipine; Physica | 1981 |
[Extracardiac hemodynamic effects of the calcium antagonist nifedipine].
Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Hemodynamics; Humans; Nifedipine; | 1981 |
Influence of changes in arterial blood pressure and peripheral arterial resistance on peak systolic velocity ratio.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Female; Femoral Arter | 1998 |
Effect of hemodynamic conditions on sonographic measurements of peak systolic velocity and arterial diameter in patients with peripheral arterial stenosis.
Topics: Administration, Oral; Angiography; Arterial Occlusive Diseases; Blood Flow Velocity; Exercise Test; | 2000 |
Using full probability models to compute probabilities of actual interest to decision makers.
Topics: Arterial Occlusive Diseases; Bayes Theorem; Clinical Trials as Topic; Coronary Disease; Decision Mak | 2001 |
Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening.
Topics: Animals; Arterial Occlusive Diseases; Cold Temperature; Collateral Circulation; Coronary Disease; Do | 1979 |
[Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Calcium; Coronary Disease; Hu | 1977 |
Recurrent attacks of amaurosis fugax treated with calcium channel blocker.
Topics: Aged; Arterial Occlusive Diseases; Blindness; Carotid Artery Diseases; Carotid Artery, Internal; Hum | 1991 |
Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebral Arte | 1991 |
[Mechanism of action of calcium antagonists in the treatment of vascular diseases].
Topics: Arterial Occlusive Diseases; Calcium; Calcium Channel Blockers; Cerebrovascular Circulation; Flunari | 1986 |
[Preoperative hemodynamic evaluation of aorto-iliac obstructive disease].
Topics: Aged; Aorta, Abdominal; Arterial Occlusive Diseases; Collateral Circulation; Hemodynamics; Humans; I | 1987 |
Effects of nifedipine on coronary reactive and exercise induced hyperaemia.
Topics: Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Hy | 1987 |
Coronary dilator effects of intracoronary nifedipine and isosorbide dinitrate.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Blood Pressure; Coronary Vessels; Drug Th | 1987 |
Brachial artery stenosis secondary to ergotism and responsive to nifedipine.
Topics: Arterial Occlusive Diseases; Brachial Artery; Ergotism; Female; Humans; Middle Aged; Nifedipine | 1986 |
Nifedipine and arterial steal syndrome.
Topics: Arterial Occlusive Diseases; Humans; Male; Middle Aged; Nifedipine; Renal Dialysis | 1986 |
Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Cardiac Catheterization; Cardiac Pacing, | 1985 |
Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure.
Topics: Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Circulation; Coronary Disea | 1985 |
Myocardial ischaemia produced by ergonovine-induced vasoconstriction during preexisting coronary stenosis: experimental conditions for the geometric theory.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Constriction, Pathologic; Coronary Circulation | 1985 |
[Clinical and hemodynamic effects of nifedipine administered sublingually in obliterating arteriopathies of lower limbs].
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Electrocardiography; Female; Hemodynamics; Humans | 1985 |
The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart | 1985 |